Regulations.gov document
Attachment 2 - "Product Description, Acetaminophen, Caffeine and Dihydrocodeine…
Supporting & Related Material · FDA-2011-P-0096 · posted Feb 25, 2011
Key facts
| Document ID | FDA-2011-P-0096-0003 |
|---|---|
| Title | Attachment 2 - "Product Description, Acetaminophen, Caffeine and Dihydrocodeine Bitartrate-Acetaminophen, Caffeine and Dihydrocodeine Bitartrate Tablet" - [Larken Laboratories, Inc. (Sovereign Pharmaceuticals, LLC - Citizen Petition] |
| Document type | Supporting & Related Material |
| Subtype | CP-Citizen Petition (Supporting & Related Materials) |
| Agency | FDA |
| Docket | FDA-2011-P-0096 |
| Posted | Feb 25, 2011 |
| Effective date | Feb 15, 2011 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: